In the present study, we provided that lncRNA TUG1 might be a novel target for IH treatment and extended the mechanism by which TUG1 affected IH progression by regulating the miR-137/IGFBP5 axis. This evidence concerns the gene IGFBP5 and isolated hemihyperplasia.